Abstract
Breteler and colleagues1 have provided us with data indicating a reduction in the risk of incident Alzheimer’s disease (AD) with elective statin use in the largest cohort investigation to date...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Journal of Neurology, Neurosurgery & Psychiatry
Paper Title
Journal
Date
